Metropolitan Life Insurance Company (MetLife)’s Outset Medical OM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-185	Closed	-$15K	–	2336
2023 Q4	$15K	Hold	185	–	–	﹤0.01%	2038
2023 Q3	$30.1K	Hold	185	–	–	﹤0.01%	1679
2023 Q2	$60.6K	Hold	185	–	–	﹤0.01%	1313
2023 Q1	$51K	Sell	185 -17	-8%	-$6.24K	﹤0.01%	1381
2022 Q4	$78.3K	Hold	202	–	–	﹤0.01%	1205
2022 Q3	$48.3K	Hold	202	–	–	﹤0.01%	1479
2022 Q2	$45.1K	Hold	202	–	–	﹤0.01%	1572
2022 Q1	$138K	Sell	202 -605	-75%	-$364K	﹤0.01%	1004
2021 Q4	$558K	Hold	807	–	–	0.01%	1355
2021 Q3	$598K	Sell	807 -60	-7%	-$40.9K	0.01%	1332
2021 Q2	$650K	Buy	867 +651	+301%	+$498K	0.01%	1340
2021 Q1	$176K	Hold	216	–	–	﹤0.01%	2110
2020 Q4	$184K	Buy	+216	New	+$166K	﹤0.01%	1986

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OM Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Outset Medical (OM) in Q1 2024, closing a stake of 185 shares — an estimated $15K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OM in Q4 2020 and held it in 13 quarters. The position peaked at $650K in Q2 2021. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 185 Outset Medical shares in Q1 2024, an estimated $15K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Outset Medical in Q4 2020 and held it in 13 quarters.
Metropolitan Life Insurance Company (MetLife)'s Outset Medical position peaked at $650K in Q2 2021.
114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.